T. Rowe Price Associates’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$55K Buy
2022
Q1
$89K Sell
2021
Q4
$201K Sell
2021
Q3
$8.67M Buy
2021
Q2
$2.09M Buy
2020
Q3
Sell
2020
Q2
$3.57M Sell
2020
Q1
$3.8M Sell
2019
Q4
$5.46M Buy